Aphthous ulcers

Dermatologic Therapy

Volumn 23, Issue 3, 2010, Pages 281-290

  Messadi, Diana V ^a   Younai, Fariba ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Aphthae; Oral; Therapy

Indexed keywords

AMLEXANOX; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BENZOCAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CETYLPYRIDINIUM SALT; CHLORHEXIDINE GLUCONATE; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CYANOCOBALAMIN; DAPSONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; LEVAMISOLE; LIDOCAINE; NICORANDIL; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; POLIDOCANOL; PREDNISONE; TETRACAINE; TETRACYCLINE; THALIDOMIDE; TRICLOSAN; UNINDEXED DRUG; ANTIVIRUS AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; APHTHOUS ULCER; BURNING SENSATION; CELLULAR IMMUNITY; CHEILITIS; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DYSGEUSIA; FAMILY HISTORY; FATIGUE; FLU LIKE SYNDROME; GENETIC PREDISPOSITION; GENITAL ULCER; HEART ARRHYTHMIA; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOPATHOGENESIS; LIPODYSTROPHY; LOW DRUG DOSE; LUPUS LIKE SYNDROME; LYMPHOMA; METHEMOGLOBINEMIA; MOON FACE; MORNING DOSAGE; MOUTH LESION; MOUTH ULCER; NAUSEA; NEUROPATHY; OSTEOPENIA; OSTEOPOROSIS; PATIENT EDUCATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION; SORE THROAT; THRUSH; ULCER HEALING; BEHCET SYNDROME; PATHOLOGY; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC;

EID: 77952689188     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01324.x     Document Type: Review

References (49)

1. Ship II. Epidemiologic aspects of recurrent aphthous ulcerations. Oral Surg Oral Med Oral Pathol 1972 : 33 : 400 406.
2. Ship II, Morris AL, Surocher RT, Burket L Recurrent aphthous ulceration in a professional school student population. I.V. twelve month study of natural disease patterns. Oral Surg Oral Med Oral Pathol 1961 : 14 : 30 39.
3. Chattopadhyay A, Chatterjee S. Risk indicators for recurrent aphthous ulcers among adults in the US. Community Dent Oral Epidemiol 2007 : 35 : 152 159.
4. Shulman JD. An exploration of point, annual, and lifetime prevalence in characterizing recurrent aphthous stomatitis in USA children and youths. J Oral Pathol Med 2004 : 33 : 558 566.
5. Jurge S, Kuffer R, Scully C, Porter SR. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Diseases 2006 : 12 : 1 21.
6. Scully C. Clinical practice. Aphthous ulceration. N Engl J Med 2006 : 13 : 355, 165 172.
7. Femiano F, Lanza A, Buonaiuto C, et al. Guidelines for diagnosis and management of aphthous stomatitis. Pediatr Infect Dis J 2007 : 26 : 728 732.
8. Borra RC, Andrade PM, Silva ID, et al. The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med 2004 : 33 : 140 146.
9. Sun A, Wang JT, Chia JS, Chiang CP. Levamisole can modulate the serum tumor necrosis factor-α level in patients with recurrent aphthous ulcerations. J Oral Pathol Med 2006 : 35 : 111 116.
10. Saulsbury FT, Wispelwey B. Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J Pediatr 2005 : 146 : 283 285.
11. Ben Slama L. Aphthae and aphthosis. Rev Stomatol Chir Maxillofac 2003 : 104 : 295 297.
12. Guimaraes AL, de Sa AR, Victoria JM, et al. Association of interleukin 1-betapolymorphism with recurrent aphthous stomatitis in Brazilian individuals. Oral Dis 2006 : 12 : 580 583.
13. Scully C, Porter S. Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management. J Oral Pathol Med 1989 : 18 : 21 27.
14. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun 2002 : 3 : 302 305.
15. Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tchorzewski H. Predominance of type 1 cytokines and decreased number of CD4+CD25high T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett 2005 : 99 : 57 62.
16. Broides A, Yerushalmi B, Levy R, et al. Imerslund-Grasbeck syndrome associated with recurrent aphthous stomatitis and defective neutrophil function. J Pediatr Hematol Oncol 2006 : 28 : 715 719.
17. Vucicevic Boras V, Savage NW. Recurrent aphthous ulcerative disease: presentation and management. Australian Dental Journal 2007 : 52 : 10 15.
18. Healy CM, Thornhill MH. An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs. J Oral Pathol Med 1995 : 24 : 46 48.
19. Boulinguez S, Sommet A, Bedane C, Viraben R, Bonnetblanc JM. Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med. 2003 : 32 : 482 485.
20. Scully C, Porter S. Oral mucosal disease: Recurrent aphthous stomatitis. B J Oral Maxillofac Surg 2008 : 46 : 198 206.
21. Rogers RS. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 1997 : 16 : 278 283.
22. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int 2002 : 31 : 95 112.
23. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001 : 58 : 41 50.
24. Keogan MT. Clinical Immunology Review Series: An approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol 2009 : 156 : 1 11.
25. Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010 : 99 (2 178 184.
26. Munoz-Corcuera G, Esparza-Gomez MA, Gonzalez-Moles MA, Bascones-Martinez A. Oral ulcers: clinical aspects. A tool for dermatologists. Part I. Acute ulcers. Clin Exp Dermatol 2009 : 34 : 289 294.
27. Femiano F, Gombos F, Scully C. Sweet's syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 : 95 : 324 327.
28. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 2005 : 52 : 500 508.
29. Merchant NE, Ferguson MM, Ali A, et al. The detection of IgA reticulin antibodies and their incidence in patients with recurrent aphthae. J Oral Med 1986 : 41 : 31 34.
30. Green PH, Cellier C. Celiac disease. N Engl J Med 2007 : 357 : 1731 1743.
31. Altenburg A, Zouboulis CC. Current concepts in the treatment of recurrent aphthous stomatitis. Skin Therapy Lett 2008 : 13 : 1 4.
32. Altenburg A, Abdel-Naser MB, Seeber H, Abdallah M, Zouboulis CC. Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 2007 : 21 : 1019 1026.
33. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm107296.htm 2009-02-27. Accessed December 2009.
34. Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Hayrinen-Immonen R. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 2004 : 33 : 221 234.
35. Hayrinen-Immonen R, Sorsa T, Nordstrom D, Malmstrom M, Konttinen YT. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Pathol Med 1994 : 23 : 269 272.
36. Skaare AB, Herlofson BB, Barkvoll P. Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). J Clin Peridontol 1996 : 23 : 778 781.
37. Field EA, Allan RB. Review article: oral ulceration - aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment Pharmacol Ther 2003 : 18 : 949 962.
38. Taylor LJ, Walker DM, Bagg J. A clinical trial of prostaglandin E2 in recurrent aphthous ulceration. Br Dent J 1993 : 175 : 125 129.
39. Casiglia JM. Recurrent aphthous stomatitis: Etiology, diagnosis and treatment. Gen Dent 2002 : 50 : 157 166.
40. Fontes V, Machet L, Huttenberger B, et al. Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases. Ann Dermatol Venereol 2002 : 129 : 1365 1369.
41. Handfield-Jones S, Allen BR, Littlewood SM. Dapsone use with oral-genital ulcers. Br J Dermatol 1985 : 113 : 501.
42. Lynde CB, Bruce AJ, Rogers RS. Successful treatment of complex aphthosis with colchicine and dapsone. Arch Dermatol 2009 : 145 : 273 276.
43. Zhu, YL, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol 2001 : 45 : 420 434.
44. Aparecida M, de Abreu MM, Watashi CH, Hirata D, Pimentel DR, Weckx LL. Treatment of recurrent aphthous stomatitis with clofazimine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009 : 108 : 714 721.
45. Paterson DL, Georghiou PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995 : 20 : 250 254.
46. Thornhill MH, Baccaglini L, Theaker E, Pemberton MN. A randomized, double blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 2007 : 143 : 463 470.
47. Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: A randomized, double-blind, placebo-controlled trial. J Am Board Fam Med 2009 : 22 : 9 16.
48. Ship JA. Recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 : 81 : 141 147.
49. Andrews VH, Hall HR. The effects of relaxation/imagery training on recurrent aphthous stomatitis: a preliminary study. Psychosom Med 1990 : 52 : 526 535.